1535 / 1983
Conclusions
Most studies suggest there is no increased risk of breast recurrence in
BRCA 1/2
carriers at 10 years and longer follow-up
Age is the strongest predictor of local recurrence
Added benefit from tamoxifen and / or oophorectomy
Added benefit from chemotherapy
New targeted treatments could change the prognosis of these cancers